VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes-Reference-Cited by-同舟云学术

VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes

Published:2015-01 Issue: Volume:89 Page:18-29
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Calin Manuela,Stan Daniela,Schlesinger Martin,Simion Viorel,Deleanu Mariana,Constantinescu Cristina Ana,Gan Ana-Maria,Pirvulescu Monica Madalina,Butoi Elena,Manduteanu Ileana,Bota Marian,Enachescu Marius,Borsig Lubor,Bendas Gerd,Simionescu Maya

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference36 articles.

1. Inflammation in atherosclerosis: a cause or a result of vascular disorders?;Manduteanu;J. Cell Mol. Med.,2012

2. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells;Rot;Annu. Rev. Immunol.,2004

3. Anti-chemokine small molecule drugs: a promising future?;Proudfoot;Expert Opin. Investig. Drugs,2010

4. Immunoliposomes directed toward VCAM-1 interact specifically with activated endothelial cells – a potential tool for specific drug delivery;Voinea;Pharm. Res.,2005

5. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo;Gosk;Biochim. Biophys. Acta,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potentials of peptide-derived nanoformulations in atherosclerosis: present status and future directions;International Journal of Smart and Nano Materials;2024-07-02

2. Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases;Pharmaceutics;2024-02-05

3. Biomimetic Nanocarriers of Pro‐Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis;Advanced Healthcare Materials;2023-11-08

4. Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs;Materials Today Bio;2023-10

5. Targeted Nanocarriers for Systemic Delivery of IRAK4 Inhibitors to Inflamed Tissues;Small;2023-09-13